ICD-10 Code B40.3 | Cutaneous blastomycosis Symptoms, Diagnosis, Billing

Cutaneous blastomycosis is a fungal infection caused by the organism Blastomyces dermatitidis, primarily affecting the skin. It is clinically significant due to its potential to cause severe skin lesions and systemic complications if left untreated. The ICD-10 Code B40.3 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management of this condition.

What is ICD-10 Code B40.3 for Cutaneous blastomycosis?

ICD-10 Code B40.3 represents Cutaneous blastomycosis, a skin manifestation of the systemic fungal infection caused by Blastomyces dermatitidis. This code should be used in clinical documentation and billing when a patient presents with skin lesions characteristic of this infection, ensuring proper identification and management of the condition.

ICD-10 Code B40.3 – Clinical Definition and Explanation of Cutaneous blastomycosis

Cutaneous blastomycosis is caused by the inhalation of spores from the fungus Blastomyces dermatitidis, leading to skin lesions that may progress to systemic involvement. Prompt medical attention is crucial to prevent complications such as disseminated disease.

Key Clinical Features:

• Painless, raised skin lesions that may ulcerate
• History of exposure to endemic areas (e.g., soil, decaying organic matter)
• Possible systemic symptoms such as fever and malaise
• Lesions may appear as verrucous or nodular

ICD-10 Code B40.3 for Cutaneous blastomycosis – SOAP Notes & Clinical Use

ICD-10 Code B40.3 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans for Cutaneous blastomycosis. It is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B40.3 for Cutaneous blastomycosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B40.3 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Cutaneous blastomycosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B40.3 – Cutaneous blastomycosis

Hospitalization may be necessary for severe cases of Cutaneous blastomycosis, particularly if systemic involvement is suspected. Antifungal therapy is the primary treatment approach.

Antibiotic Therapy:

• Itraconazole (first-line) for 6-12 months
• Fluconazole (alternative) for 6-12 months
• Amphotericin B for severe cases or disseminated disease
• Voriconazole (alternative in refractory cases)

Supportive Care:

• Wound care for skin lesions
• Pain management as needed
• Monitoring for systemic symptoms
• Nutritional support if indicated

Infection Control:

• Standard precautions to prevent spread
• Education on avoiding exposure to endemic areas
• Monitoring for outbreaks in at-risk populations

How to Document Symptoms of Cutaneous blastomycosis (ICD-10 B40.3) in SOAP Notes

Subjective:

• Patient reports painless skin lesions on the arms and legs
• History of exposure to wooded areas
• Complaints of fatigue and mild fever
• No known allergies or previous fungal infections

Objective:

• Skin examination reveals multiple raised, ulcerated lesions
• Vital signs: Temp 100.4°F, HR 88 bpm, BP 120/80 mmHg
• Laboratory tests show elevated white blood cell count
• Chest X-ray may show pulmonary involvement

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Cutaneous blastomycosis (ICD-10 Code B40.3)

Assessment:

• Diagnosis: Cutaneous blastomycosis, moderate severity
• ICD-10 Code: B40.3
• Contributing factors: Recent outdoor activities in endemic areas
• Consider differential diagnoses such as other fungal infections

Plan:

• Initiate treatment with itraconazole for 6 months
• Educate patient on skin care and monitoring for systemic symptoms
• Schedule follow-up in 4 weeks to assess treatment response
• Consider referral to infectious disease specialist if no improvement

Treatment & Plan Section for ICD-10 Code B40.3 – Cutaneous blastomycosis

• First-line treatment with itraconazole or amphotericin B for severe cases
• Patient education on recognizing worsening symptoms
• Regular follow-up appointments to monitor treatment efficacy
• Consider lifestyle modifications to reduce exposure to fungal spores

Using ICD-10 Code B40.3 for Cutaneous blastomycosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes
• Use B40.3 for billing when Cutaneous blastomycosis is diagnosed
• Align treatment plans with clinical guidelines to support billing
• Include relevant CPT codes for associated services

Related ICD-10 Codes Often Used with Cutaneous blastomycosis

• B40.0 – Pulmonary blastomycosis
• B40.1 – Disseminated blastomycosis
• B40.2 – Blastomycosis, unspecified

ICD-10 Code B40.3 in Medical Billing and Insurance for Cutaneous blastomycosis

ICD-10 Code B40.3 is crucial for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis
• Use B40.3 in conjunction with appropriate CPT codes for services rendered
• Ensure compliance with payer requirements for documentation
• Review coding guidelines regularly to maintain accuracy

Common CPT Pairings: